Rob Carlson

Bioeconomy Capital

Rob Carlson is the Managing Director at Bioeconomy Capital, which invests in early stage biotechnology companies, and is a Principal at Biodesic, a consulting firm that focuses on strategy, security, and engineering at the intersection of biotechnology and the economy.

At the broadest level, Dr. Carlson is interested in the future role of biology as a human technology. He has worked to develop new biological technologies in both academic and commercial environments, focusing on molecular measurement and microfluidic systems. Dr. Carlson has also developed a number of new technical and economic metrics for measuring the progress of biological technologies. Carlson is the author of the book Biology is Technology: The Promise, Peril, and New Business of Engineering Life, published in 2010 by Harvard University Press; it received the PROSE award for the Best Engineering and Technology Book of 2010 and was named to the Best Books of 2010 lists by writers at both The Economist and Foreign Policy. Carlson earned a doctorate in Physics from Princeton University in 1997.

Be Part of the Revolution!

Next program starts Winter 2017. Early applications due August 30th!